JMID - ETF AI Analysis

Top Page

Janus Henderson Mid Cap Growth Alpha ETF (JMID)

Rating:72Outperform

Price Target:―

JMID, the Janus Henderson Mid Cap Growth Alpha ETF, earns a solid overall rating mainly because several of its larger positions—like Comfort Systems USA (FIX), Dexcom (DXCM), Idexx Laboratories (IDXX), Vertiv (VRT), and Corpay (CPAY)—show strong financial performance, positive earnings call sentiment, and generally supportive technical trends, which together provide a strong growth-oriented foundation. The rating is held back somewhat by holdings such as Ameriprise Financial (AMP), Cencora (COR), and Sysco (SYY), where issues like weaker revenue or margins, high leverage, bearish or weak technical signals, and valuation concerns introduce added risk. Overall, the main risk factor is that many key holdings are richly valued and some carry high debt or operational challenges, which could make the ETF more sensitive to market volatility or economic slowdowns.

Positive Factors

Strong Top Holdings

Several of the largest positions, such as Comfort Systems, Vertiv Holdings, and Medpace, have shown strong year-to-date gains, helping support the fund’s overall performance.

Broad Sector Diversification

The ETF spreads its investments across many sectors, including industrials, consumer cyclical, health care, technology, and financials, which helps reduce reliance on any single industry.

Moderate Expense Ratio

The fund’s expense ratio is moderate for an actively managed mid-cap growth strategy, so fees are not excessively high relative to its category.

Negative Factors

Recent Short-Term Weakness

Despite a positive year-to-date result, the ETF has shown weak performance over the last three months, indicating recent pressure on returns.

Concentrated in U.S. Market

With almost all assets invested in U.S. companies and only a very small allocation to the UK, the fund offers limited geographic diversification.

Exposure to Lagging Holding

One of the top holdings, Expedia, has delivered weak year-to-date performance, which can drag on the fund if the stock continues to struggle.

JMID vs. SPDR S&P 500 ETF (SPY)

AUM17.42M

RegionNorth America

Expense Ratio0.30%

Beta1.18

IssuerJanus Henderson

Inception DateSep 17, 2024

Dividend Yield0.76%

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume2,597

30 Day Avg. Volume7,931

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

34.76

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering80

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

JMID Summary

The Janus Henderson Mid Cap Growth Alpha ETF (JMID) invests mainly in medium-sized U.S. companies that are trying to grow quickly, rather than tracking a specific index. It spreads money across many areas of the economy, including industrials, consumer companies, health care, and technology. Well-known names in the fund include Expedia and Cardinal Health. Someone might invest in JMID to seek higher growth than large, established companies while still avoiding the smallest, riskiest stocks. A key risk is that growth-focused mid-cap stocks can be more volatile and can go up and down more than the overall market.

How much will it cost me?The Janus Henderson Mid Cap Growth Alpha ETF (JMID) has an expense ratio of 0.3%, which means you’ll pay $3 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed, aiming to select mid-cap stocks with strong growth potential rather than tracking a broad index.

What would affect this ETF?The Janus Henderson Mid Cap Growth Alpha ETF (JMID) could benefit from economic growth and innovation in sectors like technology and consumer cyclical, as well as increased spending in industries such as healthcare and financials. However, it may face challenges from rising interest rates, which can negatively impact growth-focused companies, and economic slowdowns, which could reduce consumer spending and industrial activity. Its U.S. focus also makes it sensitive to domestic regulatory changes and geopolitical events.

JMID Top 10 Holdings

JMID is leaning hard into U.S. mid-cap growth, with industrial standouts Vertiv and Comfort Systems doing much of the heavy lifting as their momentum keeps climbing. Howmet Aerospace adds to that industrial engine, giving the fund a clear tilt toward economically sensitive names. On the flip side, Ameriprise and Idexx are losing a bit of steam, acting more like brakes than boosters lately. Steadier health-care players like Cencora and Cardinal Health help smooth the ride, but this ETF’s story is mostly about industrial strength driving performance.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
VRT	Vertiv Holdings	5.07%	$889.80K	$102.64B	216.30%	77 Outperform
HWM	Howmet Aerospace	4.77%	$836.38K	$100.90B	102.32%	67 Neutral
COR	Cencora	3.79%	$666.07K	$68.14B	37.91%	70 Neutral
FIX	Comfort Systems	3.13%	$549.24K	$49.50B	326.28%	80 Outperform
AMP	Ameriprise Financial	2.85%	$499.78K	$41.09B	-6.20%	64 Neutral
IDXX	Idexx Laboratories	2.42%	$424.87K	$47.82B	45.62%	78 Outperform
TPR	Tapestry	2.40%	$420.92K	$29.44B	102.84%	69 Neutral
DXCM	Dexcom	2.29%	$401.99K	$25.52B	-6.29%	79 Outperform
CPAY	Corpay Inc	2.28%	$400.16K	$22.49B	-1.03%	75 Outperform
SYY	Sysco	2.09%	$366.41K	$40.50B	14.83%	71 Outperform

JMID Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

29.69

Negative

100DMA

29.55

Negative

200DMA

29.37

Negative

Market Momentum

MACD

-0.14

Positive

RSI

41.89

Neutral

STOCH

30.40

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For JMID, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 29.59, equal to the 50-day MA of 29.69, and equal to the 200-day MA of 29.37, indicating a bearish trend. The MACD of -0.14 indicates Positive momentum. The RSI at 41.89 is Neutral, neither overbought nor oversold. The STOCH value of 30.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JMID.

JMID Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
JMID	―	―	$17.42M	0.30%	72 Outperform
MID.ETF	―	―	$89.88M	0.45%	68 Neutral
KMID	―	―	$39.97M	0.80%	70 Neutral
TSCM	―	―	$39.54M	0.55%	71 Outperform
MMID	―	―	$33.08M	0.59%	66 Neutral
MCDS	―	―	$7.27M	0.35%	68 Neutral

Performance Comparison

JMID

Janus Henderson Mid Cap Growth Alpha ETF

28.94

3.54

13.94%

MID.ETF

American Century Mid Cap Growth Impact ETF

―

KMID

Virtus KAR Mid-Cap ETF

―

TSCM

TimesSquare Quality Mid Cap Growth ETF

―

MMID

MFS Active Mid Cap ETF

―

MCDS

JPMorgan Fundamental Data Science Mid Core ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents